The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation.
about
Heparan sulfate 3-O-sulfation: a rare modification in search of a function.Revisiting the association of cationic groove-binding drugs to DNA using a Poisson-Boltzmann approach.Specific sides to multifaceted glycosaminoglycans are observed in embryonic development.Exploiting enzyme specificities in digestions of chondroitin sulfates A and C: production of well-defined hexasaccharidesProbing structural selectivity of synthetic heparin binding to Stabilin protein receptorsInvestigating changes in the gas-phase conformation of Antithrombin III upon binding of Arixtra using traveling wave ion mobility spectrometry (TWIMS).Glycosaminoglycans from earthworms (Eisenia andrei).Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.Insights into the role of 3-O-sulfotransferase in heparan sulfate biosynthesis.Effects of glycosylation on heparin binding and antithrombin activation by heparin.Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins.Asparagine 405 of heparin lyase II prevents the cleavage of glycosidic linkages proximate to a 3-O-sulfoglucosamine residue.A polymer nanoparticle with engineered affinity for a vascular endothelial growth factor (VEGF165).Antithrombin stabilisation by sulfated carbohydrates correlates with anticoagulant activity
P2860
Q33690545-4B4ABAAA-BD22-47FD-B632-6A1471C82BBAQ34032654-32C819B9-CB34-4129-A15E-CE37CBA0BB6BQ34071237-1EAC7946-6921-4212-A56A-36165A53572BQ34161904-BBA23FEE-B238-4BCD-9960-38CEABEAF19CQ36033096-F4833C7E-1712-4570-BA25-BB612E6C8437Q36101652-3329FFF6-A386-4D27-BB0E-9A90731894B5Q36394956-D3FCBD8B-683C-4517-A648-73BA3A4ABFCFQ37777806-38FBE6C2-F2C1-4576-9892-06A259819545Q38287587-30261E60-D91A-4680-9827-74957D2FF11CQ38333301-1E32DA23-712A-467A-9F3E-03F2F2E060F9Q39683706-FEAB564E-07A6-4E0C-80C5-6419EF04D65EQ42045001-48D9F51F-B686-49CD-951D-84BF2F1205C1Q46507852-6BAE660B-1854-406C-881A-41039D420267Q56833674-673E6053-E6E1-4186-93EE-F833ED04C0E9
P2860
The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The signature 3-O-sulfo group ...... red for allosteric activation.
@en
The signature 3-O-sulfo group ...... red for allosteric activation.
@nl
type
label
The signature 3-O-sulfo group ...... red for allosteric activation.
@en
The signature 3-O-sulfo group ...... red for allosteric activation.
@nl
prefLabel
The signature 3-O-sulfo group ...... red for allosteric activation.
@en
The signature 3-O-sulfo group ...... red for allosteric activation.
@nl
P2093
P2860
P356
P1476
The signature 3-O-sulfo group ...... red for allosteric activation.
@en
P2093
Benjamin Richard
Richard Swanson
Steven T Olson
P2860
P304
27054-27064
P356
10.1074/JBC.M109.029892
P407
P577
2009-08-06T00:00:00Z